400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cell Cycle / DYRK / GSK-626616
CAS No.: 1025821-33-3
GSK 626616 is a potent and selective DYRK inhibitor with IC50 of 0.7 nM for DYRK3, similar potency for DYRK1 and 2.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00443170 | Healthy Subjects ... more >> Anaemia Collapse << | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4006 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 Collapse << |
实验方案
技术信息
CAS号 | 1025821-33-3 | 储存条件 |
|
|
分子式 | C18H10Cl2N4OS | 运输 | 蓝冰 | |
分子量 | 401.27 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00443170 | Healthy Subjects ... more >> Anaemia Collapse << | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4006 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网